David Seemungal

David Seemungal is a seasoned professional with extensive experience in the healthcare and investment sectors. He currently serves as the Distribution Lead at RYSE Asset Management.1 With over 25 years of experience in healthcare investment, policy, and distribution, Seemungal has held several prominent positions throughout his career.1

Career Highlights

Healthcare Expertise:: Seemungal's background includes roles such as Head of Pharmaceutical & Biotechnology Equity Research at ING's investment banking division, Deputy Head at S&P Global, and Senior Policy Advisor at the Wellcome Trust.1

Consulting and Business Development:: He is the owner of Cubase Consulting Limited, a position he has held since 2008.2 Additionally, Seemungal is a Director at healthcare consultancy Synopia.13

Current Roles:: Apart from his position at RYSE Asset Management, Seemungal is also a Director at Green Elements Trading Limited, a role he has occupied since May 2019.2

Education and Skills

Seemungal holds a first-class degree in Microbiology & Genetics from Cardiff University.1 He also has three years of postgraduate research experience at Imperial College London, which has contributed to his strong background in microbial physiology, microbiology, and genetics.1

Professional Focus

Throughout his career, Seemungal has focused on assessing the competitive landscape for new products and identifying commercial distribution partners for pharmaceutical, biotech, and medtech companies.1 His expertise in horizon scanning and analyzing commercial research opportunities has been particularly valuable in his roles at the Wellcome Trust and in his consulting work.1

David Seemungal's diverse experience in healthcare investment, policy, and distribution, combined with his scientific background, positions him as a valuable asset in the healthcare and investment sectors.